Welcome to our dedicated page for Ascent Industries Co. SEC filings (Ticker: ACNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ascent Industries Co. (ACNT) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Ascent describes itself as a specialty chemicals platform focused on tailored, performance-driven chemical solutions, and its filings give detailed insight into how this business is structured and financed.
Key documents include periodic reports such as Forms 10-K and 10-Q, where Ascent presents financial statements, segment information, and discussions of factors affecting its specialty chemicals operations and Chemicals-as-a-Service (CaaS) model. These filings also elaborate on the company’s use of non-GAAP measures like EBITDA and Adjusted EBITDA, with reconciliations to GAAP metrics.
Current reports on Form 8-K highlight material events, including amendments to the company’s credit facility, divestitures of Bristol Metals, LLC (BRISMET) and American Stainless Tubing, Inc. (ASTI), lease modifications related to former tubular facilities, adoption of Rule 10b5-1 trading plans for share repurchases, and announcements of financial results. Other filings, such as proxy statements on Schedule 14A, provide information on director elections, advisory votes on executive compensation, and auditor ratification.
On Stock Titan, users can view these filings alongside AI-powered summaries that explain the key points of lengthy documents, helping to interpret complex credit facility amendments, lease agreements, or capital allocation disclosures. Real-time updates from EDGAR ensure that new Ascent filings appear promptly, while access to historical reports and, where applicable, insider transaction filings such as Form 4 allows investors to examine trends in governance, capital structure, and management’s reported decisions over time.
Giannantonio Carmen Joseph reported acquisition or exercise transactions in this Form 4 filing.
ASCENT INDUSTRIES CO. director Carmen Joseph Giannantonio reported receiving a grant of 976 shares of common stock as compensation. The award is recorded at $13.315 per share, and these 976 shares are his total reported direct holdings after the transaction. The shares vest on June 10, 2026.
ASCENT INDUSTRIES CO. director Carmen Joseph Giannantonio filed an initial Form 3, which is a statement of beneficial ownership for insiders. This filing establishes his status as a reporting person at the company and does not list any insider transactions in the reported data.
Rohen Jeremy reported acquisition or exercise transactions in this Form 4 filing.
Ascent Industries Co. director Jeremy Rohen received an equity grant of common stock as compensation. He was awarded 2,159 shares of Common Stock at a reference price of $13.315 per share, and these shares vest on June 10, 2026. Following this grant, he holds 2,159 shares directly, reflecting a routine director stock award rather than an open-market purchase.
ASCENT INDUSTRIES CO. director Jeremy Rohen filed an initial Form 3, which is the required statement of his beneficial ownership when he became a reporting insider. The filing shows no reported transactions in company securities at this time.
Ascent Industries Co. Schedule 13G/A reports that Mink Brook affiliates beneficially hold an aggregate of 886,769 shares of common stock as of the close of business on March 31, 2026. The filing states those shares represent 9.6% of the class for Mink Brook Capital GP LLC and related reporting persons, using 9,243,948 shares outstanding as of March 27, 2026 as the denominator. The submission clarifies shared voting and dispositive power across Mink Brook Partners LP (500,846 shared power) and Mink Brook Opportunity Fund LP (385,923 shared power), and disclaims certain beneficial ownership by William Mueller and the GP except to the extent of pecuniary interest.
Ascent Industries Co. expanded its Board of Directors from five to seven members and appointed specialty chemicals veterans Carmen J. Giannantonio and Jeremy F. Rohen as independent directors, effective April 1, 2026. Both will serve on key committees, adding finance, M&A, and distribution expertise.
The company also adopted a Rule 10b5-1 trading plan to repurchase up to 1,750,000 shares of its common stock between March 31, 2026 and May 11, 2026 under its existing stock repurchase program. Director John P. Schauerman will not stand for re-election but will serve through the 2026 Annual Meeting.
Ascent Industries Co. filed a shelf registration to offer up to $100,000,000 of securities, consisting of common stock, debt securities, warrants, purchase contracts, rights and units, to be sold from time to time in one or more offerings.
The prospectus is a general description; specific terms, amounts, prices and distribution methods will be set forth in prospectus supplements. Net proceeds are expected to be used for general corporate purposes, including capital expenditures, debt reduction, acquisitions or working capital.